The Food and Drug Administration (FDA) carried out an inspection at Snap Diagnostics, LLC. in Vernon Hills on Feb. 13, as stated in data posted on the FDA’s website.
According to the inspection’s final report, Snap Diagnostics, LLC. was advised to address issues related to the management of device compliance operations. No corrective steps were required in the other assessed area.
The FDA routinely inspects facilities nationwide to verify that workplaces and their products comply with federal regulations aimed at protecting public health. Inspection outcomes are released to the public.
The FDA’s website notes that the agency’s primary roles include overseeing the safety and quality of human and animal drugs, biological products, medical supplies and tobacco products.
Information for this report comes from the U.S. Food and Drug Administration. Source data is available here.
